Lowering C-reactive protein with statins after an ischemic stroke avoids mortality and readmissions. A prospective cohort study.

Aims: A hypothetical benefit of statins after an ischemic stroke could be provided by their pleiotropic effects. Our aim is to test if statins are able to avoid mortality and readmissions of patients with ischemic stroke, by lowering their levels of not only LDL-cholesterol but also CRP.

Methods: A prospective cohort study was performed.

Mean platelet volume in acute phase of ischemic stroke, as predictor of mortality and functional outcome after 1 year.

Background: Mean platelet volume (MPV) could be a predictor of prognosis after ischemic stroke. Our aim is to investigate the association of MPV with a greater mortality and morbidity (defined as readmissions) after 1 year of follow-up in patients with acute stroke, and with a poor functional outcome in these patients.

Methods: Patients with ischemic stroke (N = 379) were recruited and assessed for an average of 46.

[C-reactive protein in the acute phase of ischemic stroke].

Background And Objective: We aimed to assess the prognostic importance of C-reactive protein (CRP) in the acute phase of ischemic stroke in-patients.

Patients And Method: One hundred and seventeen patients within 48 h after index ischemic stroke were included. CRP levels and blood samples were obtained at this time, and a brain computerized tomography or magnetic resonance imaging were performed.